Sophia Abene

Study addresses the racial and ethnic inequalities in TB incidence rates.

Study evaluates the outcomes of orthotopic liver transplantation of HIV-HBV coinfected patients.

Water sampling reveals COVID-19 trends in homeless populations.

The CDC's take on the importance of HIV awareness and testing among our youth.

A study evaluates the efficacy of nirmatrelvir-ritonavir in COVID-19 treatment across variants.

A study on Italian vaccination rates and factors influencing Rotavirus vaccine acceptance.

Study shows GBP1 assists HCV in the replication and spread against antiviral expectations.

Trial examines high-dose vs. standard-dose influenza vaccines.

Evaluating the importance of RSV vaccination implications for adults.

Emergency use authorization for CorDx TyFast Flu A/B & COVID-19.

FDA approves Zevtera a new treatment option for bacterial infections, a comprehensive look at coccidioidomycosis, the impact of guidelines on reducing hospital-onset CDI incidence, and more this week from Contagion.

Dr. Thomas Holland discusses the breakthrough in antibiotic development.

Alcohol Awareness Month highlights the need for action amidst the alcohol crisis in the US.

Examining the implications and challenges of coccidioidomycosis, histoplasmosis, and blastomycosis diagnosis during the COVID-19 pandemic.

Zevtera approval shows efficacy and marks a new treatment option for bacterial infections including MRSA.

A comprehensive look at coccidioidomycosis (valley fever) through diagnosis, treatment, prevention, and climate change impact.

Bavarian Nordic's JYNNEOS available to healthcare providers nationwide.

April marks STI Awareness Month; guidelines decreasing the incidence of chlamydia and syphilis, future work needing to be done with regards to doxy-PEP, an increase in STIs during the pandemic, and more from this year by Contagion.

Rising dengue incidence in Puerto Rico signals broadening health concerns.

A study on the impact of guidelines on reducing hospital-onset CDI incidence.

FDA authorizes Ito Invivyd’s pemivibart (Pemgarda), insights on Sofosbuvir levels in pregnant women, the effectiveness of fidaxomicin vs vancomycin for CDI treatment, and more this week from Contagion.

A surge in meningococcal disease cases linked to Serogroup Y.

Impact of the RSVPreF3 vaccine on respiratory illness in older adults in the US.

Atea Pharmaceuticals bemnifosbuvir aims to help high-risk COVID-19 patients with a new oral option.

Phase 2 study of healthcare workers' safety in high-risk populations.

The potential of enzyme cocktails for enhanced mycobacterial infection management.

Latest discoveries around HpaA's implications for immune response and disease progression.

Insights from a CDC study on challenges and research direction in pediatric hepatitis.

Bulevirtide's key role in blocking hepatitis virus entry.

The role of the US President’s Emergency Plan for AIDS Relief in combating tuberculosis (TB).